Protego Biopharma, Inc. research brief
CIK 1796909
Generated Nov. 17, 2026, 11:21 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: SAN DIEGO California. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Dec. 3, 2025 · D · 0001231919-25-000568 · Source evidence
Reported offering amount: 130442180 USD. Reported amount sold: 32942190 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Protego Biopharma, Inc. research brief,” CIK 1796909, retrieved Nov. 17, 2026, 11:21 p.m.. Cite the specific accessions used. No amounts have been summed.